ALGORAE Eyes Growth with New ASX Shares
Company Announcements

ALGORAE Eyes Growth with New ASX Shares

Living Cell Technologies Ltd. (AU:1AI) has released an update.

ALGORAE PHARMACEUTICALS LIMITED has announced its application for the quotation of 25 million newly vested ordinary shares on the ASX under the code 1AI. These shares, issued on December 28, 2023, are the result of the conversion of performance rights as detailed in a previous company notice. This move signifies a potential expansion in the company’s market presence, sparking interest among investors.

For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskLiving Cell Technologies Announces Director’s Interest Change
TipRanks Australian Auto-Generated NewsdeskAlgorae Pharmaceuticals Plans Major Securities Issuance
TipRanks Australian Auto-Generated NewsdeskAlgorae Pharmaceuticals Secures Shareholder Support at AGM
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App